Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. Objective: To examine the real-world effectiveness of mo...Read more

A research team from The University of Hong Kong found a significant drop in emergency department visits and an increase in certified deaths during th...Read more

港大醫學院最新研究顯示，新冠肺炎患者服用默沙東的莫努匹韋和輝瑞的帕昔洛韋可以降低全因死亡率、病情惡化率和在更短時間內減少病毒量。對於住院患者，兩款藥物分別可以降低52%和66%的全因死亡率，對65歲以上患者和未完成接種患者的效果更為顯著。兩藥物可以使病情惡化率下降四成。研究還發現，對於非住院患者，莫...Read more

香港大學醫學院最新研究發現，門診患者使用輝瑞新冠口服藥後，與未用藥者相比可減少24%的入院風險，而使用默沙東藥者則無顯著差別。香港昨日新增5,210例確診病例，其中包括478例輸入病例，創下疫情以來的新高。另外，再有12人死亡，為近三周內最多。...

本港昨日新增3529宗新冠病毒陽性個案，當中3186宗是本地感染，343宗是輸入個案。另有3名患者離世，自第五波疫情以來累計9963人染疫不治。Omicron BA.4/BA.5樣本佔比約89.7%，BA.2.12.1佔約3.2%。立法會議員田北辰稱，「0+0」入境檢疫勢在必行，又預計最早今個星期、...Read more

醫管局前行政總裁梁栢賢建議使用「超額死亡」作為放寬社交距離措施的標準。《刺血針》發表了一項涵蓋191個國家和地區的超額死亡研究，結果顯示，超額死亡比報告的新冠死亡數字高出1266萬。專家解釋數據統計如何幫助決策者籌劃下一步。澳大利亞、新西蘭、新加坡和台灣等國家的超額死亡為負數，意味著在疫情期間死亡人...Read more

本港在年初第五波新冠肺炎疫情高峰期，開始向確診者處方輝瑞或默沙東新冠口服藥。港大醫學院一項研究發現，兩款口服藥均有效減低死亡率和入院後病情惡化，滿60歲患者更有助減低住院風險。不過，就未完成接種新冠疫苗的確診者，默沙東口服藥對減死亡和入住風險無明顯幫助。醫學院稱，數據會交醫生和政府參考，但不宜建議處...Read more

Background: With accruing case reports on de novo or relapsing glomerular diseases (GD) following different severe acute respiratory syndrome coronavi...Read more

Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more

Background Data on the effectiveness of oral antivirals in patients with mild-to-moderate COVID-19 are urgently needed. This retrospective cohort stu...Read more

Background: Observable symptoms of Bell's palsy following vaccinations arouse concern over the safety profiles of novel coronavirus disease 2019 (COVI...Read more

Importance: COVID-19 has required universities to rapidly develop vaccination policies for students and staff, yet little is known about the preferenc...Read more

Objectives: There was initially insufficient understanding regarding suitable pharmacological treatment for pediatric Coronavirus Disease 2019 (COVID-...Read more

Background: Safety after the second dose of the SARS-CoV-2 vaccine remains to be elucidated, especially among individuals reporting adverse events aft...Read more

Prior research using electronic health records for Covid-19 vaccine safety monitoring typically focuses on specific disease groups and excludes indivi...Read more

Objective: T2DM patients with COVID-19 were associated with increased risk of hyperinflammation and hence poor prognosis. Inconclusive evidence sugges...Read more

Objective: We tested a model of individual health literacy information sharing with family members, personal preventive behaviours and family well-bei...Read more

Elevations in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were reported as adverse events of nirmatrelvir/ritonavir users in t...Read more

BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more